FindTrial
Sign In

Developing and validating of clinical prediction model for novel coronavirus pneumonia (COVID-19) patients progressing to critical type, acute respiratory distress syndrome and death: a medical records based study

Developing and validating of clinical prediction model for novel coronavirus pneumonia (COVID-19) patients progressing to critical type, acute respiratory distress syndrome and death

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032527
Enrollment
Unknown
Registered
2020-05-01
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

non-critical group:no
critical group:no
ARDS group:no
non-ARDS group:no
survival group:no
non-survival group:no

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria for confirmed COVID-19

Exclusion criteria

Exclusion criteria: 1) aged <18 years; 2) pregnant; 3) length of hospital <24 hours; 4) insufficient clinical information; 5) serious complications not directly related to the COVID0-19 (including but not limited to surgical emergencies, intracranial hemorrhage, multiple injuries, etc.); 6) existing critical type, ARDS at hospital admission.

Design outcomes

Primary

MeasureTime frame
In hospital mortality;—

Secondary

MeasureTime frame
morbidity of critical type;morbidity of ARDS;—

Countries

China

Contacts

Public ContactShusheng Li

Eergency / Intensive Care Department of Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology

shushengli16@sina.com+86 13971086498

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026